Author: Graham Simon Matthew Howgate Daniel Anderson William Howes Claire Heliotis Manolis Mantalaris Athanassios Tsiridis Eleftherios Tsapakis Evangelia
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.10, Iss.4, 2011-07, pp. : 575-602
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Calcium ± vitamin D breaks the risk of osteoporosis and fracture
Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. :
Teriparatide reduces fracture risk in postmenopausal osteoporosis
Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. :
Prolactin and Antipsychotic Medication
Child and Adolescent Psychopharmacology News, Vol. 12, Iss. 5, 2007-10 ,pp. :
Long-term PPI use increases osteoporosis-related fracture risk
Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. :
Long-term PPI use increases osteoporosis-related fracture risk
Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. :